WOC

The WOC Skin Health Weekly®, a weekly e-news publication packed with career empowerment resources including the latest clinical, industry, and product news, clinical education, market research, and of course, the most recently posted jobs requiring expertise in the prevention and treatment of skin breakdown and wound care. Over 20,000 clinicians now receive the WOC Skin Health Weekly.

Read the most recent issue of the WOC Skin Health Weekly®

Receive your own complimentary subscription to the WOC Skin Health Weekly®

Sign Up Now!


Featured Articles

August 8, 2017

Complimentary Wound Care Clinical Education Webcast: "Nutrition & Wound Healing: Connecting the Pieces." Featuring, Karen Turbett, BSN, RN, CWOCN, CFN. Space is limited! Register today!

Ensuring at-risk residents receive the proper equipment, and care, for preventing or treating pressure injuries is critical to not only the health of the resident, but also to the health of your facility’s bottom line and reputation. Register Now

Percutaneous Deep Vein Arterialization System Safe, Effective for "No-Option" CLI

Early clinical results in a small cohort demonstrate safety and feasibility of a percutaneous deep vein arterialization system for the treatment of patients with critical limb ischemia who have no traditional endovascular or surgical revascularization options. The system features ultrasound-guided catheters and covered nitinol stents to bypass diseased arteries and divert blood flow into the tibial vein, according to a company release. Read More

'Origami Organs' can Potentially Regenerate Tissues

Scientists and engineers have invented a range of bioactive 'tissue papers' made of materials derived from organs that are thin and flexible enough to even fold into an origami bird. The new biomaterials can potentially be used to support natural hormone production in young cancer patients and aid wound healing.  Read More

Researchers Get $1.4 Million To Study Treatments For Intestinal Inflammation

The principal investigators' research will focus on defining specific factors and cells that may be targeted to treat IBD. They will test whether nanoparticle-mediated manipulation of pro- and anti-inflammatory factors can limit intestinal inflammation and promote wound healing during IBD. To accomplish this, they will use advanced approaches employing siRNA nanoparticles that target key pro-healing and anti-inflammation factors, which are involved in the pathogenesis of IBD. Read More